About Us - Drug Development Technology

Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Advertise with us

APIs

Vaccine development: the need for speed

Lack of CMO availability threatens cell and gene therapy development

Novaliq’s NovaTears+Omega-3 represents the first-in-class omega-3-containing eye drop for evaporative dry eye

Approvals

February’s top news stories

January’s top news stories

DMAb trial for Zika prevention gets FDA approval

Clinical Research

February’s top news stories

January’s top news stories

Women’s health pipeline: profiling the GCPR target class

Clinical Trials

Biogen and Eisai end two Alzheimer’s drug trials

Amgen, Cytokinetics and Servier heart failure drug trial to continue

Innovent doses first patient in trial to treat hypercholesterolemia

Diseases

February’s top news stories

Tisotumab vedotin shows promise in treating six cancer types

Pulmatrix to initiate Phase II trial of Pulmazole

Genomics & Proteomics

August’s top news stories

July’s top news stories

June’s top news stories

Market Data

Deals this week: Voyager Therapeutics, Pulmatrix, Horizon Discovery

Deals this week: PeptiDream, Proteus Digital Health, Novartis

Deals this week: Ferring Pharmaceuticals, Mirati, Juvenescence

Technology

February’s top news stories

January’s top news stories

Find out how pharma is fighting respiratory illnesses in the latest Pharma Technology Focus

Online

Read more

In Print

Read more